In a note submitted today to The ALS Association's website, which discusses the way the ALS Association use this incredible outpouring of support to combat ALS, Barbara Newhouse, President and CEO of The ALS Association said: Related StoriesNeurological tests accessibility and affordability: an interview with Dr Joseph Higgins’Nothing you’ve seen prior have we experienced a better position to fuel our fight this disease. Increased awareness and unprecedented financial support shall enable us to believe outside the box.Why is there too little adequate regulatory handles, treatment guidelines and individual awareness in relation to antibiotic resistance? I think this is an excellent issue because if we can come up with the answer there may be improvements. I think one answer is that the problem here is not the condition itself but rather the problem of undermining the effects of important medications that cure the condition. If we undermine the result of antibiotics by permitting level of resistance to develop, we prevent their curative results. The global world is not able to visualize this as a real consequence.